AR027195A1 - Composicion para el cuidado de la piel que interviene en la comunicacion entre las celulas - Google Patents
Composicion para el cuidado de la piel que interviene en la comunicacion entre las celulasInfo
- Publication number
- AR027195A1 AR027195A1 ARP000106653A ARP000106653A AR027195A1 AR 027195 A1 AR027195 A1 AR 027195A1 AR P000106653 A ARP000106653 A AR P000106653A AR P000106653 A ARP000106653 A AR P000106653A AR 027195 A1 AR027195 A1 AR 027195A1
- Authority
- AR
- Argentina
- Prior art keywords
- cells
- communication
- derivatives
- intervening
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000008568 cell cell communication Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 abstract 1
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 abstract 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 abstract 1
- 102000014171 Milk Proteins Human genes 0.000 abstract 1
- 108010011756 Milk Proteins Proteins 0.000 abstract 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 abstract 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 abstract 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 abstract 1
- 150000003835 adenosine derivatives Chemical class 0.000 abstract 1
- 229950006790 adenosine phosphate Drugs 0.000 abstract 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 abstract 1
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 210000002510 keratinocyte Anatomy 0.000 abstract 1
- 235000021239 milk protein Nutrition 0.000 abstract 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 210000004927 skin cell Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940119463 sunflower seed extract Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Existen composiciones conocidas para el tratamiento de la piel que contienen compuestos senalados de la célula, que inducen y promueven la biosíntesis y/ola bioactividad de los químicos endogenos que intervienen en la comunicacion entre las células d e la piel entre los queratinocitos, fibroblastos y otros tiposde células. El compuesto senalado de la célula se selecciona del grupo que comprende: andrografolida y sus derivados; fosfato cíclico de adenosina y susderivados; proteínas de leche hidrol izadas; extracto de semillas de girasol; extracto de plancton; fitol y sus derivados; y mezclas de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46144999A | 1999-12-14 | 1999-12-14 | |
US19098800P | 2000-03-21 | 2000-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027195A1 true AR027195A1 (es) | 2003-03-19 |
Family
ID=26886624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000106653A AR027195A1 (es) | 1999-12-14 | 2000-12-14 | Composicion para el cuidado de la piel que interviene en la comunicacion entre las celulas |
Country Status (14)
Country | Link |
---|---|
US (3) | US20020006383A1 (es) |
EP (1) | EP1152731B1 (es) |
JP (2) | JP2003516950A (es) |
CN (1) | CN100366248C (es) |
AR (1) | AR027195A1 (es) |
AU (1) | AU774676B2 (es) |
BR (1) | BR0008214A (es) |
CA (1) | CA2364300C (es) |
DE (1) | DE60031836T2 (es) |
HK (1) | HK1042044B (es) |
MX (1) | MXPA01006553A (es) |
PL (1) | PL201625B1 (es) |
TW (1) | TWI281413B (es) |
WO (1) | WO2001043704A1 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001256570A1 (en) * | 2000-05-05 | 2001-11-20 | Dr. Reddy's Research Foundation | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them |
EP1512405B1 (en) * | 2002-05-20 | 2013-08-14 | Otsuka Pharmaceutical Co., Ltd. | Composition comprising adenosine monophosphate for treating melasma |
FR2847469B1 (fr) * | 2002-11-26 | 2006-04-07 | Oreal | Utilisation de l'adenosine ou d'un analogue d'adenosine, pour lisser les rides d'expression |
FR2847470B1 (fr) * | 2002-11-26 | 2004-12-31 | Oreal | Composition, notamment cosmetique, comprenant l'adenosine et des sels de magnesium et potassium |
FR2849377B1 (fr) * | 2002-12-30 | 2007-08-03 | Jean Noel Thorel | Composition cosmetique, regulatrice de la flore cutanee |
FR2849376B1 (fr) * | 2002-12-30 | 2007-07-13 | Jean Noel Thorel | Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique |
US9114156B2 (en) * | 2002-12-30 | 2015-08-25 | Aplicare, Inc. | Enhanced antimicrobial skin preparation |
CN100408571C (zh) * | 2003-02-25 | 2008-08-06 | 北京医工生物技术研究所 | 穿心莲内酯三马来酸半酯及其盐和它们的药物组合物 |
DE10324256B4 (de) | 2003-05-28 | 2010-04-22 | Merz Pharma Gmbh & Co. Kgaa | Lipid-Tranferprotein-Systeme und deren kosmetische/dermatologische Anwendung |
DE10355743A1 (de) † | 2003-11-28 | 2005-07-07 | Wella Ag | Verwendung von Peptiden zum Schutz der Haut vor Haarbehandlungsmitteln |
JP2005179286A (ja) * | 2003-12-22 | 2005-07-07 | Nikko Chemical Co Ltd | ヒアルロン合成促進剤の皮膚老化防止剤への利用 |
DE102004020060B3 (de) * | 2004-04-20 | 2005-06-02 | Coty B.V. | Kosmetisches Verfahren zur Behandlung der Haut mit Sonnenprodukten und Sonnenprodukt-Kombination |
FR2877218B1 (fr) * | 2004-11-04 | 2007-02-09 | Jean Noel Thorel | Composition dermocosmetique destinee a repondre aux troubles de la pigmentation |
US7453077B2 (en) * | 2005-11-05 | 2008-11-18 | Cymer, Inc. | EUV light source |
JP2007176934A (ja) * | 2005-11-30 | 2007-07-12 | Kose Corp | 血小板活性化因子アセチルヒドロラーゼ機能調整剤 |
US20070160696A1 (en) * | 2006-01-11 | 2007-07-12 | The Procter & Gamble Company | Compositions and methods useful for prevention or treatment of respiratory illness |
US20070183995A1 (en) * | 2006-02-09 | 2007-08-09 | Conopco, Inc., D/B/A Unilever | Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same |
FR2899584B1 (fr) * | 2006-04-11 | 2008-05-16 | Oreal | Composition cosmetique antirides |
US20120070473A1 (en) * | 2007-08-17 | 2012-03-22 | Anhese Llc | Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions |
CA2749750C (en) * | 2008-04-15 | 2014-01-28 | Immanence Integrale Dermo Correction Inc. | Skin care compositions and methods of use thereof |
JP5047358B2 (ja) * | 2008-06-24 | 2012-10-10 | 森永乳業株式会社 | 検体中に含まれる微生物の生菌数測定に用いられる懸濁用希釈液および生菌数測定方法 |
US20100129299A1 (en) * | 2008-11-21 | 2010-05-27 | Singleton Laura C | Topical sunscreen compositions for mitigating effects on intracellular ion concentration |
US20100260695A1 (en) * | 2009-04-09 | 2010-10-14 | Mary Kay Inc. | Combination of plant extracts to improve skin tone |
EP2538956A4 (en) * | 2010-02-22 | 2015-04-22 | Edge Therapeutics Inc | METHODS AND COMPOSITIONS FOR TREATING HEMORRHAGIC BRAIN DISORDERS |
EP2568814A4 (en) * | 2010-05-14 | 2013-12-04 | James J Messina | BROTH SPECTRUM HARMFUL ANTI-ANIMAL ANTI-ANIMAL COMPOSITIONS AND PEST CONTROL SYSTEM |
CN102985093A (zh) | 2010-06-25 | 2013-03-20 | 大塚制药株式会社 | 用于遏制光暴露导致的异常皮肤细胞的形成的试剂 |
US8795640B2 (en) | 2011-12-22 | 2014-08-05 | Mary Kay Inc. | Lip formulation |
WO2013149323A1 (en) * | 2012-04-02 | 2013-10-10 | Ntegrity | Natural products for skin care |
JP2015514769A (ja) * | 2012-04-20 | 2015-05-21 | ザ プロクター アンド ギャンブルカンパニー | 顔の毛穴の外観を改善するための組成物及び方法 |
MX2016010005A (es) * | 2014-02-07 | 2016-10-07 | Unilever Nv | Una composicion topica. |
DE202015004868U1 (de) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | Topische Hautzusammensetzung und deren Verwendung |
CN107205387B (zh) * | 2015-02-02 | 2020-11-13 | 默克专利股份有限公司 | 包含防虫剂的粉末配制剂 |
US10076479B1 (en) | 2018-05-08 | 2018-09-18 | Avon Products, Inc. | Methods for treating skin |
US9956151B2 (en) * | 2015-03-05 | 2018-05-01 | Avon Products, Inc. | Methods for treating skin |
CN105380849A (zh) * | 2015-11-25 | 2016-03-09 | 陕西艾美雅生物科技有限公司 | 一种化妆品及其使用方法 |
CN105380848A (zh) * | 2015-11-25 | 2016-03-09 | 陕西艾美雅生物科技有限公司 | 一种组合物及其制备方法、含有该组合物的化妆品及其使用方法 |
CN109646672A (zh) * | 2019-01-10 | 2019-04-19 | 石家庄正扬头道生物科技有限公司 | 一种stm乌发药剂 |
FR3110573B1 (fr) * | 2020-05-20 | 2024-01-19 | Exsymol Sa | Compositions comprenant des composés organo-silanols, et applications. |
CN114795996B (zh) * | 2022-04-08 | 2023-08-29 | 广东先强药业有限公司 | 一种含有核苷类成分的组合物及其应用 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1467955A1 (de) * | 1964-05-12 | 1969-02-06 | Hugo Janistyn | Kosmetische Zubereitung von Phytol und/oder Phytolderivaten |
US3978213A (en) * | 1972-07-10 | 1976-08-31 | Nelson Research & Development Company | Cosmetic use of cyclic amp and phosphodiesterase inhibitors |
FR2474829B1 (fr) * | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications |
DE3035022A1 (de) * | 1980-09-17 | 1982-04-22 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung und reinigung von phenoxyazolyl-butanon-derivaten |
DE3201511A1 (de) * | 1982-01-20 | 1983-07-28 | Henkel Kgaa | Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten |
FR2557452B1 (fr) | 1983-12-28 | 1986-08-14 | Roussel Uclaf | Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate |
JPS61178908A (ja) * | 1984-02-27 | 1986-08-11 | Kanebo Ltd | 皮膚化粧料 |
US5686489A (en) * | 1986-12-23 | 1997-11-11 | Tristrata Technology, Inc. | Alpha hydroxyacid esters for skin aging |
US5126376A (en) * | 1988-06-24 | 1992-06-30 | Stephen Herman | Method for treating viral infection using topical administration |
FR2657256B1 (fr) | 1990-01-24 | 1994-09-16 | Claude Bonne | Nouvelles preparations cosmetiques contenant un extrait de tourteaux de tournesol (helianthus annuus). |
US5262552A (en) * | 1990-02-20 | 1993-11-16 | Asahi Denka Kogyo K.K. | Optically active compounds and intermediates thereof, and process for manufacturing same |
DE69127020T2 (de) * | 1990-05-18 | 1998-01-29 | Iwase Cosfa Co Ltd | Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel |
JP2895572B2 (ja) | 1990-05-18 | 1999-05-24 | 森永乳業株式会社 | 化粧料及び皮膚外用剤 |
EP0513354A1 (en) * | 1990-08-31 | 1992-11-19 | Dainippon Ink And Chemicals, Inc. | Antioxidizing composition and composition containing the same |
WO1992008685A1 (fr) * | 1990-11-14 | 1992-05-29 | L'oreal | Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes |
FR2687314A1 (fr) * | 1992-02-18 | 1993-08-20 | Oreal | Dispersion de vesicules lipidiques, composition cosmetique et/ou pharmaceutique la contenant et procede de preparation de ladite dispersion. |
US5741518A (en) * | 1992-08-03 | 1998-04-21 | L'oreal | Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids |
JP3080797B2 (ja) | 1992-12-01 | 2000-08-28 | ポーラ化成工業株式会社 | ペプチドを含有する化粧料 |
US5484597A (en) * | 1993-07-30 | 1996-01-16 | Chesebrough-Pond's Usa Co. | Clear hydroalcholic cosmetic microemulsions |
US5602109A (en) * | 1994-01-10 | 1997-02-11 | Abbott Laboratories | Method to enhance the immune system of a human |
US5541225A (en) * | 1994-10-11 | 1996-07-30 | The General Hospital Corporation | α-Linolenic acid and eicosatetraynoic acid in the prevention and treatment of ventricular tachyarrhythmia |
WO1996017605A1 (en) * | 1994-12-06 | 1996-06-13 | Paracelsian, Inc. | Use of andrographolide compounds to treat or prevent pathogenicity of diseases |
JPH0930946A (ja) * | 1995-07-21 | 1997-02-04 | Shiseido Co Ltd | 美白用皮膚外用剤 |
GB9602111D0 (en) * | 1996-02-02 | 1996-04-03 | Unilever Plc | Personal care composition |
JPH1029927A (ja) | 1996-07-12 | 1998-02-03 | Shiseido Co Ltd | 抗老化剤 |
JPH10114648A (ja) | 1996-10-11 | 1998-05-06 | Kao Corp | 皮膚外用組成物 |
JPH10167957A (ja) | 1996-12-09 | 1998-06-23 | Kao Corp | 細胞間接着抑制剤 |
DE19804837A1 (de) * | 1998-01-29 | 1999-08-05 | Coty Bv | Kosmetisches Produkt zur Regenerierung und Stimulierung der Hautzellen |
-
2000
- 2000-12-14 EP EP00984306A patent/EP1152731B1/en not_active Expired - Lifetime
- 2000-12-14 MX MXPA01006553A patent/MXPA01006553A/es active IP Right Grant
- 2000-12-14 DE DE60031836T patent/DE60031836T2/de not_active Expired - Lifetime
- 2000-12-14 AU AU20946/01A patent/AU774676B2/en not_active Ceased
- 2000-12-14 BR BR0008214-7A patent/BR0008214A/pt not_active Application Discontinuation
- 2000-12-14 JP JP2001544645A patent/JP2003516950A/ja not_active Withdrawn
- 2000-12-14 AR ARP000106653A patent/AR027195A1/es active IP Right Grant
- 2000-12-14 CA CA2364300A patent/CA2364300C/en not_active Expired - Fee Related
- 2000-12-14 PL PL349174A patent/PL201625B1/pl unknown
- 2000-12-14 WO PCT/US2000/033776 patent/WO2001043704A1/en active IP Right Grant
- 2000-12-14 CN CNB008028184A patent/CN100366248C/zh not_active Expired - Fee Related
-
2001
- 2001-02-05 TW TW089126748A patent/TWI281413B/zh not_active IP Right Cessation
- 2001-03-20 US US09/812,707 patent/US20020006383A1/en not_active Abandoned
-
2002
- 2002-05-02 HK HK02103296.3A patent/HK1042044B/zh not_active IP Right Cessation
- 2002-07-19 US US10/198,772 patent/US20030035819A1/en not_active Abandoned
-
2005
- 2005-01-21 US US11/040,534 patent/US7960437B2/en not_active Expired - Fee Related
-
2007
- 2007-04-25 JP JP2007114980A patent/JP4658994B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001043704A8 (en) | 2001-10-04 |
US20030035819A1 (en) | 2003-02-20 |
HK1042044A1 (en) | 2002-08-02 |
AU774676B2 (en) | 2004-07-01 |
AU2094601A (en) | 2001-06-25 |
CA2364300A1 (en) | 2001-06-21 |
PL201625B1 (pl) | 2009-04-30 |
DE60031836T2 (de) | 2007-06-28 |
HK1042044B (zh) | 2007-06-08 |
US20020006383A1 (en) | 2002-01-17 |
EP1152731B1 (en) | 2006-11-15 |
PL349174A1 (en) | 2002-07-01 |
WO2001043704A1 (en) | 2001-06-21 |
CN100366248C (zh) | 2008-02-06 |
DE60031836D1 (de) | 2006-12-28 |
EP1152731A1 (en) | 2001-11-14 |
US20050129723A1 (en) | 2005-06-16 |
BR0008214A (pt) | 2001-10-30 |
JP2007191493A (ja) | 2007-08-02 |
MXPA01006553A (es) | 2002-03-14 |
EP1152731A4 (en) | 2002-10-30 |
US7960437B2 (en) | 2011-06-14 |
CA2364300C (en) | 2012-10-16 |
TWI281413B (en) | 2007-05-21 |
JP2003516950A (ja) | 2003-05-20 |
CN1364073A (zh) | 2002-08-14 |
JP4658994B2 (ja) | 2011-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR027195A1 (es) | Composicion para el cuidado de la piel que interviene en la comunicacion entre las celulas | |
ES2190195T3 (es) | Utilizacion de al menos un extracto proteico de granos de plantas del genero moringa y composicion cosmetica y/o farmaceutica correspondiente. | |
BR0009763A (pt) | Sequências de ácido nucléico para proteìnas envolvidas na sìntese de tocoferol | |
DZ3402A1 (fr) | Cyclopentanoindoles, compositions contenant ces composes et methodes de traitement | |
PT863891E (pt) | (metilsulfonil)fenil-2-(5h)furanonas como inibidores de cox-2 | |
HRP20060251A2 (en) | Substituted oxasolidinones and their use | |
ES2032899T3 (es) | Agente cosmetico para aplicacion externa y su uso. | |
BR0109780A (pt) | Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas | |
ES2178250T3 (es) | Derivados de aminofenol y su utilizacionm en cosmetica. | |
PT1246809E (pt) | Compostos de 5-aril-1h-1,2,4-triazole como inibidores de ciclooxigenase-2 e composicoes farmaceuticas que os contem | |
BR112022001897A2 (pt) | Composições de higiene pessoal | |
MX172298B (es) | Composiciones cosmeticas novedosas que contienen un extracto de partes aereas cichorium intybus l | |
ES2146269T3 (es) | Composicion cosmetica para la piel. | |
NO20021859L (no) | Nye oligosakkarider, deres fremstilling samt farmasöytiske preparater inneholdende oligosakkaridene | |
KR20120052460A (ko) | 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물 | |
BR9916004A (pt) | Inibidores de proteinase c de pró-colágeno | |
BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
AR024846A1 (es) | Composiciones cosmeticas para el cuidado de la piel que contienen 4-cromanona. | |
AR021843A1 (es) | Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion. | |
AR026491A1 (es) | Composiciones cosmeticas que contienen extracto de semillas de anis en combinacion con retinoides | |
DK1635776T3 (da) | Lipidoverföringsproteinsystemer samt deres kosmetiske dermatologiske anvendelse | |
ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
EE200100125A (et) | TAN-1057 derivaadid | |
YU60101A (sh) | Derivati rezorcinola | |
ES2193297T3 (es) | Agentes que previenen el mal olor humano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |